Cargando…
Expediting COVID-19 vaccination increases QALYs and saves costs in the USA
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159657/ https://www.ncbi.nlm.nih.gov/pubmed/34075293 http://dx.doi.org/10.1007/s40274-021-7735-7 |
Ejemplares similares
-
Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021) -
Remote pulse-ox monitoring for COVID-19 patients saves costs, improves outcomes in the USA
Publicado: (2021) -
COVID-19 vaccination predicted to be cost effective in USA
Publicado: (2021) -
Universal COVID-19 vaccination cost saving unless anaphylaxis rate high
Publicado: (2021) -
Lives and Costs Saved by Expanding and Expediting Coronavirus Disease 2019 Vaccination
por: Bartsch, Sarah M, et al.
Publicado: (2021)